These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 24833006)

  • 1. In situ forming implants for periodontitis treatment with improved adhesive properties.
    Do MP; Neut C; Delcourt E; Seixas Certo T; Siepmann J; Siepmann F
    Eur J Pharm Biopharm; 2014 Oct; 88(2):342-50. PubMed ID: 24833006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-situ forming composite implants for periodontitis treatment: How the formulation determines system performance.
    Do MP; Neut C; Metz H; Delcourt E; Mäder K; Siepmann J; Siepmann F
    Int J Pharm; 2015; 486(1-2):38-51. PubMed ID: 25791762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment.
    Do MP; Neut C; Metz H; Delcourt E; Siepmann J; Mäder K; Siepmann F
    Eur J Pharm Biopharm; 2015 Aug; 94():273-83. PubMed ID: 26047797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical key properties of antibiotic-free, PLGA/HPMC-based in-situ forming implants for local periodontitis treatment.
    Agossa K; Lizambard M; Rongthong T; Delcourt-Debruyne E; Siepmann J; Siepmann F
    Int J Pharm; 2017 Apr; 521(1-2):282-293. PubMed ID: 28223246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-situ forming implants for the treatment of periodontal diseases: Simultaneous controlled release of an antiseptic and an anti-inflammatory drug.
    Lizambard M; Menu T; Fossart M; Bassand C; Agossa K; Huck O; Neut C; Siepmann F
    Int J Pharm; 2019 Dec; 572():118833. PubMed ID: 31715363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Antimicrobial Agent Loaded Eudragit RS Solvent Exchange-Induced In Situ Forming Gels for Periodontitis Treatment.
    Phaechamud T; Jantadee T; Mahadlek J; Charoensuksai P; Pichayakorn W
    AAPS PharmSciTech; 2017 Feb; 18(2):494-508. PubMed ID: 27116203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
    Kilicarslan M; Koerber M; Bodmeier R
    Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxycycline hyclate-loaded bleached shellac in situ forming microparticle for intraperiodontal pocket local delivery.
    Phaechamud T; Chanyaboonsub N; Setthajindalert O
    Eur J Pharm Sci; 2016 Oct; 93():360-70. PubMed ID: 27552903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol in situ forming gel loaded with doxycycline hyclate for intra-periodontal pocket delivery.
    Phaechamud T; Setthajindalert O
    Eur J Pharm Sci; 2017 Mar; 99():258-265. PubMed ID: 28027940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of rhBMP-2 around endosseous implants with and without membranes in the canine model.
    Jones AA; Buser D; Schenk R; Wozney J; Cochran DL
    J Periodontol; 2006 Jul; 77(7):1184-93. PubMed ID: 16805681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.
    Yue IC; Poff J; Cortés ME; Sinisterra RD; Faris CB; Hildgen P; Langer R; Shastri VP
    Biomaterials; 2004 Aug; 25(17):3743-50. PubMed ID: 15020150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline Release of Dental Implants With Nanotube Surface, Coated With Poly Lactic-Co-Glycolic Acid for Extended pH-controlled Drug Delivery.
    Alécio ABW; Ferreira CF; Babu J; Shokuhfar T; Jo S; Magini R; Garcia-Godoy F
    J Oral Implantol; 2019 Aug; 45(4):267-273. PubMed ID: 31008689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants.
    Thakur RR; McMillan HL; Jones DS
    J Control Release; 2014 Feb; 176():8-23. PubMed ID: 24374003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasticized branched aliphatic oligoesters as potential mucoadhesive drug carriers.
    Snejdrova E; Dittrich M; Drastik M
    Int J Pharm; 2013 Dec; 458(2):282-6. PubMed ID: 24183958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: approaches to develop PLGA based in situ gelling system with low initial burst.
    Ahmed T
    Pak J Pharm Sci; 2015 Mar; 28(2):657-65. PubMed ID: 25730797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solvent removal precipitation based in situ forming implant for controlled drug delivery in periodontitis.
    Juvekar S; Kathpalia H
    J Control Release; 2017 Apr; 251():75-81. PubMed ID: 28242417
    [No Abstract]   [Full Text] [Related]  

  • 18. Intraoral transmission and the colonization of oral hard surfaces.
    Quirynen M; Papaioannou W; van Steenberghe D
    J Periodontol; 1996 Oct; 67(10):986-93. PubMed ID: 8910838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of clove oil in solvent exchange-induced doxycycline hyclate-loaded Eudragit RS
    Phaechamud T; Thurein SM; Chantadee T
    Asian J Pharm Sci; 2018 Mar; 13(2):131-142. PubMed ID: 32104386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of in situ forming PLA implant containing tinidazole for the treatment of periodontitis.
    Qin Y; Yuan M; Li L; Li W; Xue J
    J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2197-202. PubMed ID: 22887609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.